Significant continued rise due to receipt of a 1 billion yen guarantee from Pengbo, a Chinese company, for the introduction of Boron Neutron Capture Therapy (BNCT, a type of radiation therapy for cancer) to China's Hainan Island Medical Special Zone. Stella Pharma has already signed a basic agreement with Pengbo and other companies regarding the supply of boron medicines for BNCT. The Hainan Island Medical Special Zone project is progressing smoothly toward the start of treatment from April to June 2025, and Stella Pharma is also preparing for the supply of Steboronin.
ステラファーマ---大幅に続伸、中国の海南島医療特区へのBNCT導入で10億円の保証金受領
Stella Pharma skyrocketed significantly with the receipt of a 1 billion yen deposit for the introduction of BNCT to the Hainan Island Medical Special Zone in China.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.